ALLISON WELLING: Open Payments
NPI 1548867179 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 49 payments from 11 companies in 2025. Trend: 2023 $1,212 · 2024 $1,009 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $330 |
| Novartis Pharmaceuticals Corporation | 12 | $244 |
| LEO Pharma Inc. | 4 | $178 |
| UCB, Inc. | 6 | $162 |
| ABBVIE INC. | 11 | $159 |
| Organon LLC | 2 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $60 |
| Galderma Laboratories, L.P. | 3 | $57 |
| Incyte Corporation | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: DUPIXENT, COSENTYX, Bimzelx, ANZUPGO, SKYRIZI, RINVOQ, ILUMYA, AKLIEF.
Industry payments across MD — which companies pay providers there.
